CAR-engineered cytolytic Tregs reverse pulmonary fibrosis and remodel the fibrotic niche with limited CRS
Yunhan Jiang(Sichuan University), Yingqiang Guo(Sichuan University), Sai Chen(University of Michigan), Mengdi Cheng(Northwest University), Meng Zhou(Sichuan University)
Cited by 9
Related Papers
Discovery of common and rare genetic risk variants for colorectal cancer
|Nature Genetics|2018|605
Advancing Tumor-Targeted Chemo-Immunotherapy: Development of the CAR-M-derived Exosome-Drug Conjugate
|Journal of Medicinal Chemistry|2024|18
Characteristics of genomic mutations and signaling pathway alterations in thymic epithelial tumors
|Annals of Translational Medicine|2021|14
Forkhead box O proteins: steering the course of stem cell fate
|Cell Regeneration|2024|12
The U.S. FDA approved cardiovascular drugs from 2011 to 2023: A medicinal chemistry perspective
|European Journal of Medicinal Chemistry|2024|10